Our findings in serous ovarian carcinoma, and the previous results from studies of breast cancer and glioblastoma, are in contrast to ovarian carcinoma of endometrioid type [78], and endometrial cancer [79,80], where PTEN mutations and PIK3CA mutations frequently co-exist. This evidence concerns the gene PIK3CA and ovarian carcinoma.